Scarica l'app Stockscreener
12.97
1.33%
0.17
Dopo l'orario di chiusura:
12.79
-0.18
-1.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Is Adaptive Biotechnologies Corporation a candidate for recovery playJuly 2025 Spike Watch & Real-Time Volume Spike Alerts - Newser
What MACD signals say about Adaptive Biotechnologies CorporationMarket Activity Report & Reliable Entry Point Trade Alerts - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationJuly 2025 News Drivers & Risk Managed Investment Strategies - Newser
How to forecast Adaptive Biotechnologies Corporation trends using time seriesJuly 2025 Catalysts & Smart Swing Trading Alerts - Newser
Market reaction to Adaptive Biotechnologies Corporation’s recent newsPortfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Regression analysis insights on Adaptive Biotechnologies Corporation performance - Newser
What earnings revisions data tells us about Adaptive Biotechnologies CorporationMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesGap Down & Expert Approved Trade Ideas - Newser
Multi asset correlation models including Adaptive Biotechnologies Corporation2025 Historical Comparison & Reliable Trade Execution Plans - Newser
Published on: 2025-08-25 21:08:30 - beatles.ru
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Adaptive Biotechnologies (ADPT) Poised for $33.7M Windfall on Genentech Deal Termination - Insider Monkey
Adaptive Biotechnologies (ADPT): Evaluating Valuation Following Genentech Collaboration Wind-Down and Strategic Refocus - ca.finance.yahoo.com
What technical models suggest about Adaptive Biotechnologies Corporation’s comebackRate Cut & Expert Curated Trade Setup Alerts - Newser
Adaptive Biotechnologies stock hits 52-week high at $13.37 - Investing.com India
Is Adaptive Biotechnologies Corporation backed by strong institutional buying2025 Trading Volume Trends & Real-Time Sentiment Analysis - theviewers.co.kr
How does Adaptive Biotechnologies Corporation compare to its peersTrade Analysis Summary & Proven Capital Preservation Methods - theviewers.co.kr
Is Adaptive Biotechnologies Corporation reversing from oversold territoryJuly 2025 Breakouts & Safe Capital Growth Tips - Newser
Intraday pattern recognizer results for Adaptive Biotechnologies Corporation2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
How a Genentech cancer-fighting collaboration once valued at $2 billion ended with only $310 million paid out - The Business Journals
Adaptive Biotechnologies to end Genentech collaboration agreement in February 2026 - Investing.com
Real time scanner hits for Adaptive Biotechnologies Corporation explainedQuarterly Trade Review & Safe Entry Point Identification - Newser
Sectors Driving Future Growth for Adaptive Biotechnologies Corporation StockPortfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Adaptive Biotechnologies Outpaces Medical Sector with 109.2% Year-to-Date Gain - AInvest
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Adaptive Biotechnologies Reaches Analyst Target Price - Nasdaq
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Just Reported And Analysts Have Been Lifting Their Price Targets - ca.finance.yahoo.com
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences - 富途牛牛
Adaptive Biotechnologies’ Earnings Call Highlights Growth - The Globe and Mail
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $14 to $15 - 富途牛牛
Adaptive Biotechnologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Over - GuruFocus
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Overweight Rating | ADPT Stock News - GuruFocus
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday - Yahoo Finance
JP Morgan Maintains Overweight on Adaptive, Raises PT to $14 from $10 - AInvest
Adaptive Biotechnologies (ADPT) Rating Update: TD Cowen Raises Price Target | ADPT Stock News - GuruFocus
TD Cowen Keeps Buy Rating, Raises PT to $15 on Adaptive Biotechnologies - AInvest
Piper Sandler Raises Price Target for ADPT to $15.00 | ADPT Stock News - GuruFocus
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $11 to $15 - 富途牛牛
Adaptive Biotechnologies stock hits 52-week high at $12.50 - Investing.com India
Adaptive Biotechnologies stock hits 52-week high at $12.50 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (ADPT) Price Target Increased by JPMorg - GuruFocus
Adaptive Biotechnologies Exceeds Q2 Expectations Despite LossNews and Statistics - IndexBox
Adaptive Biotechnologies: Q2 Earnings Snapshot - New Haven Register
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... By GuruFocus - Investing.com Canada
Advanced analytics toolkit walkthrough for Adaptive Biotechnologies CorporationFree Swing Trading Entry Point Signals - Newser
Adaptive Biotechnologies’ MRD Business Powers Past Expectations - Finimize
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):